1. 1255PImpact of intralesional interleukin 2 (IL2) for in-transit melanoma in two Canadian centres. (23rd October 2018) Authors: Ernst, D S; Hayward, V; McConkey, H; Teng, X; Saettler, E; Cheng, T; Temple-Oberle, C; Gwadry-Sridhar, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 89PValidation of a 90-gene assay for tissue origin diagnosis of brain metastases. (23rd October 2018) Authors: Zheng, Y; Ding, Y; Xiao, C; Zhong, W; Teng, X; Gao, Q; Wang, Q; Sun, Y; Chen, C; Chen, L; Zhu, J; Xu, Q; Xu, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1288PThe national melanoma research registry: A fundamental for disease characterization and epidemiology. (23rd October 2018) Authors: Gwadry-Sridhar, F; McConkey, H; Teng, X; Ernst, D S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Modulation of RTK by sEcad: a putative mechanism for oncogenicity in oropharyngeal SCCs. (1st April 2014) Authors: Teng, X; Ma, L; Kyrkanides, S; Raja, V; Trochesset, D; Brouxhon, SM Journal: Oral diseases Issue: Volume 21:Number 2(2015:Mar.) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immune cell metabolism in autoimmunity. (11th March 2019) Authors: Teng, X; Li, W; Cornaby, C; Morel, L Journal: Clinical and experimental immunology Issue: Volume 197:Number 2(2019) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗